Policy watch. Good news, bad news.
Gebbie
Kristine M
KM
Center for Health Policy, Columbia University School of Nursing, New York, USA.
D019380:Anti-HIV Agents / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D023482:Bioterrorism / Q000517:prevention & control; D002017:Budgets / Q000331:legislation & jurisprudence*; D005260:Female; D015658:HIV Infections / Q000188:drug therapy* / Q000191:economics* / Q000453:epidemiology / Q000635:transmission; D006291:Health Policy / Q000191:economics* / Q000331:legislation & jurisprudence; D006801:Humans; D007231:Infant, Newborn; D009316:National Institutes of Health (U.S.) / Q000191:economics / Q000331:legislation & jurisprudence; D019829:Nevirapine / Q000008:administration & dosage / Q000191:economics / Q000627:therapeutic use*; D011247:Pregnancy; D011251:Pregnancy Complications, Infectious / Q000188:drug therapy / Q000191:economics; D012106:Research / Q000191:economics* / Q000331:legislation & jurisprudence; D013019:South Africa / Q000453:epidemiology; D014481:United States
D019380:Anti-HIV Agents; D019829:Nevirapine